The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schleifer, K. W.
Right arrow Articles by Mansfield, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schleifer, K. W.
Right arrow Articles by Mansfield, J. M.

The Journal of Immunology, Vol 150, Issue 7 2910-2919, Copyright © 1993 by American Association of Immunologists


ARTICLES

Characterization of T helper cell responses to the trypanosome variant surface glycoprotein

KW Schleifer, H Filutowicz, LR Schopf and JM Mansfield
Department of Animal Health and Biomedical Sciences, University of Wisconsin-Madison 53706.

T cell responses to the variant surface glycoprotein (VSG) previously have not been detected in animals infected with the African trypanosomes despite the fact that such animals make strong T-dependent B cell responses to VSG molecules displayed by the parasites. In the present study, we have examined B 10.BR mice for VSG-specific Th cell responses at different times after infection with Trypanosoma brucei rhodesiense clone LouTat 1. T cell populations derived from different tissues were tested for their ability to proliferate and secrete cytokines when stimulated with purified LouTat 1 VSG. Furthermore, VSG- specific T cell lines and clones were derived from immunized mice and examined for their phenotypic and functional profiles in comparison with T cell responses of infected mice. The results of this study show that VSG-specific T cells were not consistently detected in the peripheral lymphoid tissues such as spleen or lymph nodes of infected animals. In contrast, VSG Ag-specific T cells were detectable principally in the peritoneal T cell populations of infected mice. Peritoneal T cells did not proliferate in response to VSG, yet produced substantial cytokine responses when stimulated; the cytokines produced were IFN-gamma and IL-2, without detectable IL-4. The cellular phenotype of VSG-responsive T cells was that of classical Th cells in that all cells were CD4-positive and expressed the CD3 alpha/beta TCR membrane complex. Thus, the VSG appears to preferentially stimulate a Th1 cell subset response during infection. Intrinsic molecular characteristics of the VSG molecule did not induce mice to make this response, however, since VSG-specific T cell lines derived from VSG- immunized mice displayed cytokine profiles characteristic of both Th1 and Th2 cells. Isolation of Th1 clones from selected lines demonstrated that these cells displayed the same membrane-phenotypic characteristics and cytokine profiles as the T cells from infected mice. Furthermore, all Th clones were VSG type-specific, APC-dependent, and I-Ak- restricted in their responses. In summary, these experiments provide the first direct evidence for VSG-specific responses at the T cell level. T cell responses to the VSG molecule during infection appear to be anatomically compartmentalized and exhibit evidence of clonal maturation (cytokine production) but not clonal expansion (proliferation) after antigenic stimulation. The cellular phenotype and cytokine profiles predict that infection predisposes the animals to mount Th1 cell subset responses to VSG. The results of this study, including the T clones generated, provide an experimental basis for examining the regulation of VSG-specific immune responses during infection.


This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Lopez, K. P. Demick, J. M. Mansfield, and D. M. Paulnock
Type I IFNs Play a Role in Early Resistance, but Subsequent Susceptibility, to the African Trypanosomes
J. Immunol., October 1, 2008; 181(7): 4908 - 4917.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Bosschaerts, M. Guilliams, W. Noel, M. Herin, R. F. Burk, K. E. Hill, L. Brys, G. Raes, G. H. Ghassabeh, P. De Baetselier, et al.
Alternatively Activated Myeloid Cells Limit Pathogenicity Associated with African Trypanosomiasis through the IL-10 Inducible Gene Selenoprotein P
J. Immunol., May 1, 2008; 180(9): 6168 - 6175.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. J. Leppert, J. M. Mansfield, and D. M. Paulnock
The Soluble Variant Surface Glycoprotein of African Trypanosomes Is Recognized by a Macrophage Scavenger Receptor and Induces I{kappa}B{alpha} Degradation Independently of TRAF6-Mediated TLR Signaling
J. Immunol., July 1, 2007; 179(1): 548 - 556.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. H. Harris, J. M. Mansfield, and D. M. Paulnock
CpG Oligodeoxynucleotide Treatment Enhances Innate Resistance and Acquired Immunity to African Trypanosomes
Infect. Immun., May 1, 2007; 75(5): 2366 - 2373.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. Namangala, C. Sugimoto, and N. Inoue
Effects of Exogenous Transforming Growth Factor {beta} on Trypanosoma congolense Infection in Mice
Infect. Immun., April 1, 2007; 75(4): 1878 - 1885.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. H. Harris, N. M. Cooney, J. M. Mansfield, and D. M. Paulnock
Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome DNA.
Infect. Immun., August 1, 2006; 74(8): 4530 - 4537.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. B. Drennan, B. Stijlemans, J. Van Den Abbeele, V. J. Quesniaux, M. Barkhuizen, F. Brombacher, P. De Baetselier, B. Ryffel, and S. Magez
The Induction of a Type 1 Immune Response following a Trypanosoma brucei Infection Is MyD88 Dependent
J. Immunol., August 15, 2005; 175(4): 2501 - 2509.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. P. Coller, J. M. Mansfield, and D. M. Paulnock
Glycosylinositolphosphate Soluble Variant Surface Glycoprotein Inhibits IFN-{gamma}-Induced Nitric Oxide Production Via Reduction in STAT1 Phosphorylation in African Trypanosomiasis
J. Immunol., August 1, 2003; 171(3): 1466 - 1472.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
W. Noel, G. Hassanzadeh, G. Raes, B. Namangala, I. Daems, L. Brys, F. Brombacher, P. D. Baetselier, and A. Beschin
Infection Stage-Dependent Modulation of Macrophage Activation in Trypanosoma congolense-Resistant and -Susceptible Mice
Infect. Immun., November 1, 2002; 70(11): 6180 - 6187.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. M. Paulnock and S. P. Coller
Analysis of macrophage activation in African trypanosomiasis
J. Leukoc. Biol., May 1, 2001; 69(5): 685 - 690.
[Abstract] [Full Text]


Home page
J. Leukoc. Biol.Home page
B. Namangala, P. De Baetselier, W. Noël, L. Brys, and A. Beschin
Alternative versus classical macrophage activation during experimental African trypanosomosis
J. Leukoc. Biol., March 1, 2001; 69(3): 387 - 396.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
A. E. Millar, J. Sternberg, C. McSharry, X.-Q. Wei, F. Y. Liew, and C. M. R. Turner
T-Cell Responses during Trypanosoma brucei Infections in Mice Deficient in Inducible Nitric Oxide Synthase
Infect. Immun., July 1, 1999; 67(7): 3334 - 3338.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. R. Schopf, J. L. Bliss, L. M. Lavigne, C. L. Chung, S. F. Wolf, and J. P. Sypek
Interleukin-12 Is Capable of Generating an Antigen-Specific Th1-Type Response in the Presence of an Ongoing Infection-Driven Th2-Type Response
Infect. Immun., May 1, 1999; 67(5): 2166 - 2171.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Pashine, B. John, S. Rath, A. George, and V. Bal
Th1 dominance in the immune response to live Salmonella typhimurium requires bacterial invasiveness but not persistence
Int. Immunol., April 1, 1999; 11(4): 481 - 489.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. Hertz, H. Filutowicz, and J. M. Mansfield
Resistance to the African Trypanosomes Is IFN-{gamma} Dependent
J. Immunol., December 15, 1998; 161(12): 6775 - 6783.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Uzonna, R. S. Kaushik, Y. Zhang, J. R. Gordon, and H. Tabel
Experimental Murine Trypanosoma congolense Infections. II. Role of Splenic Adherent CD3+ Thy1.2+ TCR-{alpha}{beta}- {gamma}{delta}- CD4+8- and CD3+ Thy1.2+ TCR-{alpha}{beta}- {gamma}{delta}- CD4-8- Cells in the Production of IL-4, IL-10, and IFN-{gamma} and in Trypanosome-Elicited Immunosuppression
J. Immunol., December 1, 1998; 161(11): 6189 - 6197.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Magez, B. Stijlemans, M. Radwanska, E. Pays, M. A. J. Ferguson, and P. De Baetselier
The Glycosyl-Inositol-Phosphate and Dimyristoylglycerol Moieties of the Glycosylphosphatidylinositol Anchor of the Trypanosome Variant-Specific Surface Glycoprotein Are Distinct Macrophage-Activating Factors
J. Immunol., February 15, 1998; 160(4): 1949 - 1956.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. R. Schopf, H. Filutowicz, X.-J. Bi, and J. M. Mansfield
Interleukin-4-Dependent Immunoglobulin G1 Isotype Switch in the Presence of a Polarized Antigen-Specific Th1-Cell Response to the Trypanosome Variant Surface Glycoprotein
Infect. Immun., February 1, 1998; 66(2): 451 - 461.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. M. Lavigne, L. R. Schopf, C. L. Chung, R. Maylor, and J. P. Sypek
The Role of Recombinant Murine IL-12 and IFN-{gamma} in the Pathogenesis of a Murine Systemic Candida albicans Infection
J. Immunol., January 1, 1998; 160(1): 284 - 292.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.